Korro Bio (KRRO) Competitors $46.04 -0.18 (-0.39%) As of 11:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRRO vs. VCEL, AVDL, GPCR, SDGR, ABCL, JANX, RCUS, SNDX, ARDX, and STOKShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include Vericel (VCEL), Avadel Pharmaceuticals (AVDL), Structure Therapeutics (GPCR), Schrodinger (SDGR), AbCellera Biologics (ABCL), Janux Therapeutics (JANX), Arcus Biosciences (RCUS), Syndax Pharmaceuticals (SNDX), Ardelyx (ARDX), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Its Competitors Vericel Avadel Pharmaceuticals Structure Therapeutics Schrodinger AbCellera Biologics Janux Therapeutics Arcus Biosciences Syndax Pharmaceuticals Ardelyx Stoke Therapeutics Vericel (NASDAQ:VCEL) and Korro Bio (NASDAQ:KRRO) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations. Is VCEL or KRRO more profitable? Vericel has a net margin of 2.85% compared to Korro Bio's net margin of 0.00%. Vericel's return on equity of 2.47% beat Korro Bio's return on equity.Company Net Margins Return on Equity Return on Assets Vericel2.85% 2.47% 1.69% Korro Bio N/A -61.51%-42.87% Which has more volatility and risk, VCEL or KRRO? Vericel has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Korro Bio has a beta of 2.89, meaning that its stock price is 189% more volatile than the S&P 500. Which has higher earnings and valuation, VCEL or KRRO? Vericel has higher revenue and earnings than Korro Bio. Korro Bio is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVericel$249.12M6.74$10.36M$0.12277.33Korro Bio$2.27M190.44-$83.58M-$9.75-4.72 Do analysts prefer VCEL or KRRO? Vericel presently has a consensus price target of $60.40, indicating a potential upside of 81.49%. Korro Bio has a consensus price target of $86.83, indicating a potential upside of 88.61%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts clearly believe Korro Bio is more favorable than Vericel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vericel 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50Korro Bio 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in VCEL or KRRO? 13.2% of Korro Bio shares are held by institutional investors. 5.2% of Vericel shares are held by company insiders. Comparatively, 4.6% of Korro Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to VCEL or KRRO? In the previous week, Vericel and Vericel both had 1 articles in the media. Vericel's average media sentiment score of 1.76 beat Korro Bio's score of 0.00 indicating that Vericel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vericel 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Korro Bio 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryVericel beats Korro Bio on 9 of the 16 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$431.38M$2.66B$6.12B$10.57BDividend YieldN/A56.38%5.66%4.70%P/E Ratio-4.7124.3986.0827.08Price / Sales190.44531.50534.29204.46Price / CashN/A28.3526.3031.09Price / Book2.695.3612.726.66Net Income-$83.58M$32.78M$3.30B$275.86M7 Day Performance7.57%3.88%4.34%3.06%1 Month Performance38.76%10.08%7.82%10.52%1 Year Performance37.06%-3.08%73.82%33.54% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio1.5427 of 5 stars$46.04-0.4%$86.83+88.6%+37.6%$431.38M$2.27M-4.7170News CoverageVCELVericel3.1622 of 5 stars$31.79+5.2%$60.40+90.0%-25.2%$1.53B$249.12M264.94300Positive NewsAVDLAvadel Pharmaceuticals3.1236 of 5 stars$15.31-0.2%$20.86+36.2%+14.7%$1.49B$221.08M-510.3370GPCRStructure Therapeutics3.0948 of 5 stars$25.30+1.2%$68.67+171.4%-36.5%$1.44BN/A-24.10136SDGRSchrodinger3.3654 of 5 stars$20.04+3.8%$27.83+38.9%+17.6%$1.42B$207.54M-8.08790Analyst DowngradeABCLAbCellera Biologics2.8772 of 5 stars$4.87+2.7%$8.00+64.3%+136.0%$1.42B$28.83M-8.85500JANXJanux Therapeutics2.2508 of 5 stars$23.70+2.0%$78.31+230.4%-46.7%$1.40B$439K-13.1730RCUSArcus Biosciences1.6248 of 5 stars$13.34+3.9%$21.14+58.5%-19.8%$1.37B$258M-4.21500Gap UpSNDXSyndax Pharmaceuticals3.696 of 5 stars$15.56-0.8%$39.22+152.1%-17.1%$1.35B$23.68M-4.00110Analyst RevisionARDXArdelyx4.1073 of 5 stars$5.63+1.6%$11.70+107.8%-22.9%$1.34B$333.61M-24.4890STOKStoke Therapeutics2.704 of 5 stars$24.73+2.4%$25.57+3.4%+116.8%$1.32B$36.56M29.09100Gap Up Related Companies and Tools Related Companies Vericel Alternatives Avadel Pharmaceuticals Alternatives Structure Therapeutics Alternatives Schrodinger Alternatives AbCellera Biologics Alternatives Janux Therapeutics Alternatives Arcus Biosciences Alternatives Syndax Pharmaceuticals Alternatives Ardelyx Alternatives Stoke Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRRO) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
